Literature DB >> 7983681

Characterization of the acyl-CoA:amino acid N-acyltransferases from primate liver mitochondria.

M Kelley1, D A Vessey.   

Abstract

The acyl-CoA:amino acid N-acyl-transferases were partially purified from human liver mitochondria. The aralkyl transferase (ArAlk) had glycine conjugating activity toward the following compounds: benzoyl-CoA > butyryl-CoA, salicylyl-CoA > heptanoyl-CoA, indoleacetyl-CoA. Its kinetic properties and responses to salt were very similar to those of bovine ArAlk. Further, its molecular weight was found to be similar to that of the bovine enzyme, in contrast to reports from other laboratories. Thus, it was concluded that the human and bovine ArAlk are not significantly different. The human arylacetyl transferase (AAc) had glutamine conjugating activity toward phenylacetyl-CoA, but only 3-5% as much activity toward indoleacetyl-CoA or 1-naphtylacetyl-CoA, respectively. While this was similar to the bovine AAc, the two forms differed in several respects. First, the human liver AAc was insensitive to salts. Second, glycination of phenylacetyl-CoA by human AAc could only be detected at a high concentration of glycine (50 mM), and the rates were < 2% of the rate of glutamination. In contrast, glycine conjugation predominates with bovine AAc. Kinetic analysis of the glutamination of phenylacetyl-CoA by human AAc revealed a KD for phenylacetyl-CoA of 14 microM and a Km for glutamine of 120 mM. These values indicate that the human AAc is not more efficient at glutamination than the AAc from bovine liver. An AAc was purified from rhesus monkey liver and found to have similar kinetic constants to the human form. This indicates that nonprimate enzymes do not have a defect in glutamine conjugation.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7983681     DOI: 10.1002/jbt.2570090307

Source DB:  PubMed          Journal:  J Biochem Toxicol        ISSN: 0887-2082


  7 in total

Review 1.  Biosynthesis, degradation and pharmacological importance of the fatty acid amides.

Authors:  Emma K Farrell; David J Merkler
Journal:  Drug Discov Today       Date:  2008-04-03       Impact factor: 7.851

2.  N-acylethanolamines as novel alcohol dehydrogenase 3 substrates.

Authors:  Milena Ivkovic; Daniel R Dempsey; Sumit Handa; Joshua H Hilton; Edward W Lowe; David J Merkler
Journal:  Arch Biochem Biophys       Date:  2010-12-06       Impact factor: 4.013

3.  In vivo evidence that N-oleoylglycine acts independently of its conversion to oleamide.

Authors:  Shalini Chaturvedi; William J Driscoll; Brenda M Elliot; Martha M Faraday; Neil E Grunberg; Gregory P Mueller
Journal:  Prostaglandins Other Lipid Mediat       Date:  2006-10-05       Impact factor: 3.072

4.  Bm-iAANAT3: Expression and characterization of a novel arylalkylamine N-acyltransferase from Bombyx mori.

Authors:  Matthew R Battistini; Brian G O'Flynn; Christopher Shoji; Gabriela Suarez; Lamar C Galloway; David J Merkler
Journal:  Arch Biochem Biophys       Date:  2018-11-16       Impact factor: 4.013

5.  Expression, purification, and characterization of mouse glycine N-acyltransferase in Escherichia coli.

Authors:  Daniel R Dempsey; Jason D Bond; Anne-Marie Carpenter; Santiago Rodriguez Ospina; David J Merkler
Journal:  Protein Expr Purif       Date:  2014-02-25       Impact factor: 1.650

6.  Characterization of the acyl-adenylate linked metabolite of mefenamic Acid.

Authors:  Howard Horng; Leslie Z Benet
Journal:  Chem Res Toxicol       Date:  2013-02-26       Impact factor: 3.739

7.  Functional Characterisation of Three Glycine N-Acyltransferase Variants and the Effect on Glycine Conjugation to Benzoyl-CoA.

Authors:  Johann M Rohwer; Chantelle Schutte; Rencia van der Sluis
Journal:  Int J Mol Sci       Date:  2021-03-18       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.